SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001624422-22-000018
Filing Date
2022-05-13
Accepted
2022-05-13 11:37:21
Documents
4
Period of Report
2022-05-12

Document Format Files

Seq Description Document Type Size
1 6-K eryp_6-kx05122022.htm 6-K 21721
2 EX-99.1 ex-991eryp_6xkx05122022.htm EX-99.1 54647
3 GRAPHIC a6kimage.gif GRAPHIC 9539
4 GRAPHIC image.jpg GRAPHIC 9240
  Complete submission text file 0001624422-22-000018.txt   103636
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 22921103
SIC: 2836 Biological Products, (No Diagnostic Substances)